BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 14633976)

  • 1. Human placental growth hormone increases expression of the p85 regulatory unit of phosphatidylinositol 3-kinase and triggers severe insulin resistance in skeletal muscle.
    Barbour LA; Shao J; Qiao L; Leitner W; Anderson M; Friedman JE; Draznin B
    Endocrinology; 2004 Mar; 145(3):1144-50. PubMed ID: 14633976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversification of cardiac insulin signaling involves the p85 alpha/beta subunits of phosphatidylinositol 3-kinase.
    Kessler A; Uphues I; Ouwens DM; Till M; Eckel J
    Am J Physiol Endocrinol Metab; 2001 Jan; 280(1):E65-74. PubMed ID: 11120660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased P85alpha is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess.
    Barbour LA; Mizanoor Rahman S; Gurevich I; Leitner JW; Fischer SJ; Roper MD; Knotts TA; Vo Y; McCurdy CE; Yakar S; Leroith D; Kahn CR; Cantley LC; Friedman JE; Draznin B
    J Biol Chem; 2005 Nov; 280(45):37489-94. PubMed ID: 16166093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphatidylinositol 3-kinase redistribution is associated with skeletal muscle insulin resistance in gestational diabetes mellitus.
    Shao J; Yamashita H; Qiao L; Draznin B; Friedman JE
    Diabetes; 2002 Jan; 51(1):19-29. PubMed ID: 11756318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of impaired phosphatidylinositol 3-kinase activity in GLUT1-containing vesicles with malinsertion of glucose transporters into the plasma membrane of fibroblasts from a patient with severe insulin resistance and clinical features of Werner syndrome.
    Kausch C; Hamann A; Uphues I; Niendorf A; Müller-Wieland D; Joost HG; Algenstaedt P; Dreyer M; Rüdiger HW; Häring HU; Eckel J; Matthaei S
    J Clin Endocrinol Metab; 2000 Feb; 85(2):905-18. PubMed ID: 10690909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of insulin resistance postpartum is linked to enhanced skeletal muscle insulin signaling.
    Kirwan JP; Varastehpour A; Jing M; Presley L; Shao J; Friedman JE; Catalano PM
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4678-84. PubMed ID: 15356080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infusion of beta-endorphin improves insulin resistance in fructose-fed rats.
    Su CF; Chang YY; Pai HH; Liu IM; Lo CY; Cheng JT
    Horm Metab Res; 2004 Aug; 36(8):571-7. PubMed ID: 15326568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early insulin signaling cascade in a model of oxidative skeletal muscle: mouse Sol8 cell line.
    Hill RA; Strat AL; Hughes NJ; Kokta TJ; Dodson MV; Gertler A
    Biochim Biophys Acta; 2004 Sep; 1693(3):205-11. PubMed ID: 15363634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion.
    Jessen N; Djurhuus CB; Jørgensen JO; Jensen LS; Møller N; Lund S; Schmitz O
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E194-9. PubMed ID: 15339744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Gly-->Arg972 amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells.
    Hribal ML; Federici M; Porzio O; Lauro D; Borboni P; Accili D; Lauro R; Sesti G
    J Clin Endocrinol Metab; 2000 May; 85(5):2004-13. PubMed ID: 10843189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of whole-body and skeletal muscle insulin resistance after one day of hindlimb suspension.
    O'keefe MP; Perez FR; Kinnick TR; Tischler ME; Henriksen EJ
    Metabolism; 2004 Sep; 53(9):1215-22. PubMed ID: 15334387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel T608R missense mutation in insulin receptor substrate-1 identified in a subject with type 2 diabetes impairs metabolic insulin signaling.
    Esposito DL; Li Y; Vanni C; Mammarella S; Veschi S; Della Loggia F; Mariani-Costantini R; Battista P; Quon MJ; Cama A
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1468-75. PubMed ID: 12679424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced insulin action on glucose transport and insulin signaling in 7-day unweighted rat soleus muscle.
    O'Keefe MP; Perez FR; Sloniger JA; Tischler ME; Henriksen EJ
    J Appl Physiol (1985); 2004 Jul; 97(1):63-71. PubMed ID: 15004002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-3 polyunsaturated fatty acids prevent the defect of insulin receptor signaling in muscle.
    Taouis M; Dagou C; Ster C; Durand G; Pinault M; Delarue J
    Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E664-71. PubMed ID: 11832371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation.
    Moon B; Kwan JJ; Duddy N; Sweeney G; Begum N
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E106-15. PubMed ID: 12618360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice.
    Shiuchi T; Iwai M; Li HS; Wu L; Min LJ; Li JM; Okumura M; Cui TX; Horiuchi M
    Hypertension; 2004 May; 43(5):1003-10. PubMed ID: 15037562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in the early steps of the insulin-signaling system in skeletal muscle of GH-transgenic mice.
    Dominici FP; Cifone D; Bartke A; Turyn D
    Am J Physiol; 1999 Sep; 277(3):E447-54. PubMed ID: 10484356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
    Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M
    Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle.
    Cusi K; Maezono K; Osman A; Pendergrass M; Patti ME; Pratipanawatr T; DeFronzo RA; Kahn CR; Mandarino LJ
    J Clin Invest; 2000 Feb; 105(3):311-20. PubMed ID: 10675357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immobilization depresses insulin signaling in skeletal muscle.
    Hirose M; Kaneki M; Sugita H; Yasuhara S; Martyn JA
    Am J Physiol Endocrinol Metab; 2000 Dec; 279(6):E1235-41. PubMed ID: 11093909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.